1. The CDC has identified 28 cases of serious blood clots among the more than 8.7 million people in the U.S. who have received a Johnson & Johnson COVID-19 vaccine, a CDC official said May 12.
2. The FDA, on May 10, has authorized Pfizer’s COVID-19 vaccine to be used in children as young as 12.
3. States won’t receive any doses of Johnson & Johnson’s COVID-19 vaccine next week, four sources told Politico May 11.
4. Moderna said May 6 its COVID-19 vaccine is 96 percent effective in adolescents ages 12-17, according to an initial analysis of a phase 2/3 trial.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
